BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19098468)

  • 1. D2-40 immunohistochemistry--so far!
    Kalof AN; Cooper K
    Adv Anat Pathol; 2009 Jan; 16(1):62-4. PubMed ID: 19098468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ; Bailey D; Marks A
    Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression.
    Kandemir NO; Barut F; Gun BD; Keser SH; Karadayi N; Gun M; Ozdamar SO
    Pathol Oncol Res; 2011 Dec; 17(4):843-51. PubMed ID: 21479874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
    Fukunaga M
    Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L; Bailey D; Parker A
    J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histomorphometrical study in cavernous lymphangioma of the tongue.
    Yaita T; Onodera K; Xu H; Ooya K
    Oral Dis; 2007 Jan; 13(1):99-104. PubMed ID: 17241438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40.
    Dubina M; Goldenberg G
    J Am Acad Dermatol; 2009 Aug; 61(2):276-80. PubMed ID: 19615538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
    Galambos C; Nodit L
    Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unclassified epithelioid vascular tumor with hemangioendotheliomatous features and lymphatic differentiation.
    Oshiro Y; Kohashi K; Oda Y; Tsuneyoshi M; Shono Y
    Pathol Int; 2009 Jun; 59(6):410-4. PubMed ID: 19490473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
    Padgett DM; Cathro HP; Wick MR; Mills SE
    Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
    Yu H; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen.
    Naito Y; Ishii G; Kawai O; Hasebe T; Nishiwaki Y; Nagai K; Ochiai A
    Pathol Int; 2007 Sep; 57(9):618-21. PubMed ID: 17685935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
    Gomaa AH; Yaar M; Bhawan J
    Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study.
    Ramírez-Amador V; Martínez-Mata G; González-Ramírez I; Anaya-Saavedra G; de Almeida OP
    J Oral Pathol Med; 2009 Apr; 38(4):328-33. PubMed ID: 19175711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.